Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery.

scientific article published on 19 December 2017

Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/17425247.2018.1420050
P698PubMed publication ID29257904

P50authorAnna LechanteurQ59114824
Andreia AlmeidaQ59114834
Flávia SousaQ59114870
Bruno SarmentoQ37830645
P2093author name stringDébora Sgorla
Najeh Khalil
Rubiana Mainardes
Eduardo Melo
Élcio Bunhak
Osvaldo Cavalcanti
P2860cites workA composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin.Q49056376
In vitro M-like cells genesis through a tissue-engineered triple-culture intestinal model.Q51793501
Miscibility studies of the blends of chitosan with some cellulose ethersQ57344200
Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulinQ57570690
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayersQ57570794
The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epitheliumQ57570819
Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulinQ57570886
Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte systemQ57570890
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesQ26779447
Protein Internal Dynamics Associated With Pre-System Glass Transition Temperature Endothermic Events: Investigation of Insulin and Human Growth Hormone by Solid State Hydrogen/Deuterium ExchangeQ30393083
Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systemsQ33230716
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.Q38366445
The role of mucus in cell-based models used to screen mucosal drug deliveryQ38656735
Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applicationsQ38816436
Animal models of insulin resistance: A reviewQ38957579
Spices in the management of diabetes mellitusQ38963575
Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studiesQ39080286
Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular deliveryQ41988266
Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systemsQ43639438
Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug deliveryQ44659587
Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugsQ44735346
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)213-222
P577publication date2017-12-27
P1433published inExpert Opinion on Drug DeliveryQ5421203
P1476titleDevelopment and characterization of lipid-polymeric nanoparticles for oral insulin delivery
P478volume15

Reverse relations

cites work (P2860)
Q64059531Cherry Extract from L. to Improve the Resistance of Endothelial Cells to Oxidative Stress: Mucoadhesive Chitosan vs. Poly(lactic--glycolic acid) Nanoparticles
Q91905865Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy

Search more.